Jeevan Scientific Technology Intrinsic Value

Jeevan Scientific Technology intrinsic value. Jeevan Scientific Technology (JSTL) median intrinsic value is ₹67.92 from 9 valuation models (range ₹26–₹100), vs current price ₹87.33 — -22.2% downside (Trading Above Calculated Value), margin of safety -28.6%. For current market price and key ratios, visit Jeevan Scientific Technology share price today.

Market Price (CMP)
₹87.33
Primary Intrinsic Value
₹80.96
Market Cap
₹174.7 Cr
-22.2% Downside
Median Value
₹67.92
Value Range
₹26 - ₹100
Assessment
Trading Above Calculated Value
Safety Margin
-28.6%

JSTL Valuation Methods Summary — DCF, Graham Number & P/E

Jeevan Scientific Technology intrinsic value across 9 models vs current price ₹87.33 — upside/downside and value range per method. Compare with JSTL DCF valuation to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹80.96 ₹64.77 - ₹97.15 -7.3% EPS: ₹3.68, Sector P/E: 22x
Book Value Method asset ₹72.00 ₹64.80 - ₹79.20 -17.6% Book Value/Share: ₹36.00, P/B: 2.0x
Revenue Multiple Method revenue ₹88.00 ₹79.20 - ₹96.80 +0.8% Revenue/Share: ₹44.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹100.00 ₹90.00 - ₹110.00 +14.5% EBITDA: ₹20.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹67.92 ₹54.34 - ₹81.50 -22.2% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹26.20 ₹23.58 - ₹28.82 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹56.86 ₹51.17 - ₹62.55 -34.9% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹48.00 ₹43.20 - ₹52.80 -45.0% ROE: 11.1%, P/E Multiple: 12x
Graham Defensive Method conservative ₹54.60 ₹49.14 - ₹60.06 -37.5% EPS: ₹3.68, BVPS: ₹36.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

JSTL Intrinsic Value vs Market Price — All Valuation Models

Jeevan Scientific Technology fair value range ₹26–₹100 vs current market price ₹87.33 across 9 valuation models. Read JSTL dividend track record for the complete payout history and dividend yield track record.

JSTL Intrinsic Value Analysis — Undervalued or Overvalued?

Jeevan Scientific Technology median intrinsic value ₹67.92, current price ₹87.33 — Trading Above Calculated Value by 22.2%, margin of safety -28.6%.

What is the intrinsic value of JSTL?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jeevan Scientific Technology (JSTL) is ₹67.92 (median value). With the current market price of ₹87.33, this represents a -22.2% variance from our estimated fair value.

The valuation range spans from ₹26.20 to ₹100.00, indicating ₹26.20 - ₹100.00.

Is JSTL undervalued or overvalued?

Based on our multi-method analysis, Jeevan Scientific Technology (JSTL) appears to be trading above calculated value by approximately 22.2%.

JSTL Financial Health — Key Ratios vs Industry Benchmarks

Jeevan Scientific Technology financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 3.57 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 11.1% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 20.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.82x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

JSTL Cash Flow Quality — Operating & Free Cash Flow

Jeevan Scientific Technology operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹10 Cr ₹2 Cr Positive Free Cash Flow 7/10
March 2024 ₹3 Cr ₹-3 Cr Positive Operating Cash Flow 6/10
March 2023 ₹-6 Cr ₹-10 Cr Negative Cash Flow 3/10
March 2022 ₹20 Cr ₹20 Cr Positive Free Cash Flow 8/10
March 2021 ₹5 Cr ₹5 Cr Positive Free Cash Flow 8/10